Form 8-K - Current report:
SEC Accession No. 0001193125-24-272533
Filing Date
2024-12-06
Accepted
2024-12-06 17:01:59
Documents
13
Period of Report
2024-12-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d540210d8k.htm   iXBRL 8-K 33688
  Complete submission text file 0001193125-24-272533.txt   152198

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bntc-20241204.xsd EX-101.SCH 2886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20241204_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20241204_pre.xml EX-101.PRE 10836
15 EXTRACTED XBRL INSTANCE DOCUMENT d540210d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 241533062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)